![]() |
||||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Go back to clinical information and images Diagnosis: Congenital Mesoblastic Nephroma, Cellular Type Congenital renal tumors comprise 2.5-7% of all perinatal tumors. Congenital renal neoplasms include, in decreasing order of frequency, congenital mesoblastic nephroma, Wilms tumor, rhabdoid tumor, clear cell sarcoma, hamartomas, and ossifying tumor of infancy. Congenital mesoblastic nephrom (or simply mesoblastic nephroma) represents 3-10% of all pediatric renal tumors. This tumor was first described as a separate entity by Bolande et al in 1967. Prior to this, it was erroneously confused with congenital Wilms tumor (Singh SP. Mesoblastic Nephroma. In: e-Medicine; visited February 24th, 2010 [Link] There are two pathologic variants: classic and cellular. The cellular type is characterized by a high mitotic index, hypercellularity, and an atypical growth pattern with necrosis, hemorrhage, and invasion of adjacent structures. The cellular type accounts for 42-63% of cases. The cellular type has been shown to bear the t(12;15)(p13;q25) and ETV6 (chromosome 12)-NTRK3 (chromosome 15) gene fusion. These combined genes are thought to activate tyrosine kinase growth signaling. This gene fusion transcript is also reported in congenital or infantile fibrosarcoma (Singh SP. Mesoblastic Nephroma. In: e-Medicine; visited August 24th, 2017 [Link]). See the chapter: Renal Neoplasms of our Tutorial (only Spanish version). Go back to clinical information and images References
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||